financetom
Market
financetom
/
Market
/
Patanjali group to have 4 IPOs in the next 5 years announces Baba Ramdev
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Patanjali group to have 4 IPOs in the next 5 years announces Baba Ramdev
Sep 16, 2022 5:10 AM

Yoga Guru Baba Ramdev on Friday announced the initial public offering (IPO) plans for four Patanjali group companies over the next five years.

Share Market Live

NSE

While addressing a press conference in Delhi Ramdev said, "After Patanjali Foods, we aim to bring IPOs of our four other companies — Patanjali Ayurved, Patanjali Wellness, Patanjali Medicine and Patanjali Lifestyle,"

He also stated that "the action plan" is "to achieve the target of Rs 5 lakh crore market value in coming years." Currently, the group turnover is around Rs 40,000 crore.

Currently, from the brand, only Patanjali Foods is listed on the stock exchanges. In 2019, Patanjali Ayurved acquired Ruchi Soya for Rs 4,350 crore through an insolvency process.

In June 2022, Ruchi Soya Industries' name was changed to Patanjali Foods, after the company acquired parent Patanjali Ayurved's food business for Rs 690 crore.

Also read: Patanjali IPO: A look at India’s fastest growing FMCG brand’s journey

He also announced the five-year plan for the brand focusing on planning huge plantations of edible oil, proving employment to people, getting 100,000 schools under Patanjali Vishwavidhalaya affiliated with education boards and working on establishing Patanjali Foods as an FMCG company.

Meanwhile, brokerage firm HDFC Securities has initiated coverage on Patanjali Foods Limited (erstwhile Ruchi Soya) with a ‘buy’ rating with a target price of Rs 1,602. The brokerage firm has suggested that investors can look to buy the stock with a time horizon of two to three quarters.

Also read : HDFC Securities: Patanjali Foods can become large FMCG-wellness brand

Catch latest market updates with CNBCTV18.com's blog

First Published:Sept 16, 2022 2:10 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US swap spreads tighten in sign of stress
US swap spreads tighten in sign of stress
Aug 5, 2024
NEW YORK (Reuters) - Spreads on U.S. interest rate swaps over Treasuries tightened or turned more negative on Monday as long-term investors hedged their exposure in the swaps market to position for lower interest rates in a sign of concern over the sharp sell-off in stocks. In late trading, the spreads were mixed. U.S. swaps measure the cost of exchanging...
Sector Update: Energy
Sector Update: Energy
Aug 5, 2024
03:19 PM EDT, 08/05/2024 (MT Newswires) -- Energy stocks were lower late Monday afternoon, with the NYSE Energy Sector Index falling nearly 2% and the Energy Select Sector SPDR Fund (XLE) dropping 1.8%. The Philadelphia Oil Service Sector index retreated 3.5%, and the Dow Jones US Utilities index slumped 2.2%. Front-month West Texas Intermediate crude oil slid 0.3% to $73.29...
Top Cryptocurrencies Plunge; Bitcoin Hovers Near $54,000 Level
Top Cryptocurrencies Plunge; Bitcoin Hovers Near $54,000 Level
Aug 5, 2024
04:15 PM EDT, 08/05/2024 (MT Newswires) -- Major digital assets tumbled Monday with bitcoin (BTC-USD) hovering near the $54,000 level. The CoinDesk Market Index, which tracks 134 digital assets, plunged 10.6% in the past 24 hours amid selloffs on Wall Street. The Nasdaq 100 fell 3.7%, the S&P 500 shed 3.3% and the Dow Jones Industrial Average dropped 2.8%. Bitcoin...
Sector Update: Health Care Stocks Fall Monday
Sector Update: Health Care Stocks Fall Monday
Aug 5, 2024
04:03 PM EDT, 08/05/2024 (MT Newswires) -- Health care stocks fell Monday with the NYSE Health Care Index down 2.9% and the Health Care Select Sector SPDR Fund (XLV) dropping 2.6%. The iShares Biotechnology ETF (IBB) fell 2.8%. In corporate news, BioNTech (BNTX) reported a wider-than-expected loss in Q2 as global sales of the German drugmaker's COVID-19 vaccine fell amid...
Copyright 2023-2026 - www.financetom.com All Rights Reserved